One Biosciences

🎉 🎉 🎉 Congratulations to Dr. Céline Vallot on being awarded the prestigious European Research Council (ERC) Consolidator Grant 2024! At One Biosciences, we are incredibly proud of our scientific founder, whose groundbreaking work continues to shape the future of cancer research. The ERC grant will support her IGNITION project, which explores how maintaining cell lineage integrity can help intercept tumor initiation. This recognition is a testament to Céline visionary approach, combining single-cell and computational technologies to unravel the complexities of tumor evolution through her work at Institut Curie and CNRS. Her research not only advances fundamental science but also inspires our mission at One Biosciences to leverage single-cell technologies and AI for precision oncology. Thank you, Céline Vallot, for your unwavering dedication and for paving the way for innovative solutions in cancer treatment. 🚀 More about Céline Vallot: https://lnkd.in/dKNK2Dek Consolidator grants: https://lnkd.in/eYCvVgh2 Home Biosciences Magali RICHARD David Schilansky Hedi Ben Brahim #ERCGrant #CancerResearch #PrecisionMedicine #OneBiosciences #SingleCell #AI

☁️ 🔬☁️ 🔬☁️ One Biosciences has just been spotlighted by Amazon Web Services (AWS) in their famous Customer Stories series, showcasing smart use of cloud computing to accelerate innovation. Discover how we scaled up to work on multiple clinical projects through automation and AWS’s on-demand computing resources: https://lnkd.in/dKmzYZCA We leverage AI and single cell technologies to provide high-resolution omics profiling for patient selection, development of novel therapies, optimal treatment strategies and clinical trial matching. Céline Vallot Magali RICHARD Hedi Ben Brahim David Schilansky Hugo Cornu Home Biosciences #singlecell #cancerresearch #cloudcomputing

❓❓❓💡💡💡 Never heard about One Biosciences ?? Next week, you will have 3️⃣ occasions to learn how we leverage AI and single cell technologies to bring new solutions to patients, clinicians and pharma companies. Magali RICHARD, our COO, will talk at les universités de Pharmaceutiques on the 28th. Hedi Ben Brahim, our CEO, will talk at Mines Paris - PSL deeptech forum on the 26th and Healtech Accelerations Summit by BIOTECHFINANCES on the 27th. 3 great occasions to explain how our innovation is becoming a reality in the patients’journey. Come and let’s meet ! David Schilansky Céline Vallot Home Biosciences BioLabs

📰📰📰📢📢📢📢 One Biosciences à l'honneur dans Le Figaro avec un article de Marie Bartnik qui lui est consacré ! Nous développons de nouvelles solutions pour les patients qui s'appuient sur les technologies en cellule unique et l'intelligence artificielle grâce à des partenariats avec des centres d'excellence comme Institut Curie, Gustave Roussy, Greater Paris University Hospitals - AP-HP. https://lnkd.in/gGHQ5_Y2 Céline Vallot, Magali RICHARD, David Schilansky, Hedi Ben Brahim Home Biosciences BioLabs #singlecell #cancerresearch

One Biosciences and Gustave Roussy launch today a partnership to fight bladder cancer ! Combining the expertise and patient data from Gustave Roussy with the AI powered single cell discovery platform from One Biosciences will drive the emergence of new solutions and technologies for cancer patients. This is a new major project for One Biosciences which continues to accelerate to transform innovation into solutions for patients. #singlecell #fightcancer

📢📢📢📢📢 Great day for One Biosciences today at #AWSsummit in Paris Don't miss the conference at 11:15am by Hugo Cornu, Cécile H., Makram J. and Felipe Marins about how LLM can accelerate precision medicine At 2pm, Céline Vallot will pitch to present the progress brought by One Biosciences All day long, come meet us at our stand on the 3rd floor ! Mikhail Kamalov Baptiste Simon Hedi Ben Brahim Magali RICHARD David Schilansky Home Biosciences Amazon Web Services (AWS) #innovation #singlecell #llm

📰📰📰📰 One Biosciences once again highlighted in the news ! Discover in Le Monde the insights from Magali RICHARD, our COO on how AI is central for new drug discovery. Many fantastic companies in France are working to make that a reality for patients https://lnkd.in/duHVi9t3 Zeliha Chaffin Alexandre Piquard Home Biosciences Institut Curie Gustave Roussy David Schilansky Céline Vallot Hedi Ben Brahim #AI #drugdiscovery #innovation

📢📢📢📢 One Biosciences featured in the "Top 100 Startups to Invest in" ranking by Challenges magazine !   This recognition follows some impressive achievements since our inception in 2020. Here are some: -A clear technological and scientific edge established for our discovery engine (multi-modal data fueling our proprietary AI models for a clear purpose and vision) -Several discovery programs underway in oncology and beyond, in partnership with leading academic centers such as Institut Curie and Institut Gustave Roussy -A unique partnership with Greater Paris University Hospitals - AP-HP to discover new targets in a rare kidney disease -Our first targets reaching validation stage in high grade ovarian cancer   On another front, we have bolstered our leadership team with: -The appointment of a great leader, Hedi Ben Brahim, as CEO in September 2023 with a mission to aggressively scale-up the company. -The appointments of two industry leaders, Dr Scott Braunstein and Dr. Vincent Miller to our Board of Directors in March 2024.   This follows our laureate position in the « 100 Leading teams whose discovery will change lives » by Le Point Magazine last year !   A heartfelt thank you to Challenges magazine for this honor and to our partners, our co-founder Home Biosciences and very importantly to our fantastic team.   Onward and upward for patients suffering from rare diseases and hard-to-treat cancers.      #ChallengesTop100 #Biotech #Innovation #HealthcareRevolution #AI #startups

One Biosciences is thrilled to welcome two new board members.    Scott Braunstein, Chairman and CEO of Marinus Pharma and operating partner at Aisling Capital, and Vincent Miller, a global expert in cancer and clinical trial design and interpretation, are key additions to One Biosciences as we approach the launch of our drug development activities. Both are leading figures in the world of healthcare and biotechnology.    Their impressive track records and their arrival on our board are also a recognition of the excellence of our teams and the robustness of the projects we are pursuing. Together we are working to bring new treatments for cancer and rare diseases as quickly as possible. Home Biosciences Magali RICHARD David Schilansky Céline Vallot   #ai #technology #singlecell #drugdiscovery

📈☁️📈☁️📈☁️💡💡 Les données de santé sont une ressource fondamentale pour nourrir des modèles d’intelligence artificielle à même de découvrir de nouvelles thérapies pour les patients. One Biosciences est au cœur de cette révolution ! Encore faut-il l’infrastructure cloud adaptée pour les gérer. Trouver le bon compromis entre innovation est souveraineté est au cœur du débat en cours. Il est essentiel pour le secteur biotech et healthech d'avoir une solution adaptée. Retrouvez la tribune de Magali RICHARD et Hedi Ben Brahim sur ce sujet dans Les Echos aujourd'hui https://lnkd.in/d7iKGXvd #IA #cloud #donnéesdesanté